Carl Ashley Morris - 02 May 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Chief Scientific Officer
Signature
/s/ Erin P. Brennan as attorney-in-fact for Carl Ashley Morris
Issuer symbol
SLDB
Transactions as of
02 May 2022
Net transactions value
$0
Form type
4
Filing time
04 May 2022, 16:40:24 UTC
Previous filing
15 Mar 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Employee Stock Option (Right to Buy) Award $0 +296,000 $0.000000 296,000 02 May 2022 Common Stock 296,000 $0.5500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on May 2, 2022 and vests in three equal annual installments beginning on the first anniversary of the grant date.